TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

105 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Multiple sclerosis (MS)

    📍 Washington University in St. Louis · St Louis, MO · Get directions →

    This study involves a Positron Emission Tomography (PET) scan using a new investigational radioactive tracer, \[18F\]-FZTA, to detect inflammation in the brain. The tracer will be tested in healthy younger adults and individuals with Multiple Sclerosis.

    ✓ Study care freeAges 18+Learn more →
  • Depression

    Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality

    Testing how a 9-week social reward therapy changes brain activity in people with suicidal thoughts

    💵 May compensate

    📍 Weill Cornell Medicine · New York, NY · Get directions →

    The investigators hypothesized that during the 9-week course of Engage \& Connect treatment there will be an increase in brain functions of the Positive Valence System which in turn will lead to reduction in suicidality.

    ✓ Study care freeAges 50–80Learn more →
  • Rheumatoid arthritis

    Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis

    Testing a remote exercise program (aerobic and strength) for people with rheumatoid arthritis

    💵 May compensate

    📍 Duke University · Durham, NC · Get directions →

    The primary objective of this study is to assess the feasibility of an intensive, remotely-delivered, combined aerobic and resistance training exercise program for patients with Rheumatoid Arthritis (RA) and to collect data to support power calculations for a larger research study.

    ✓ Study care freeAges 18+Learn more →
  • Fatty liver disease (NASH/MASH)

    A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

    Testing how efimosfermin alfa compares with placebo for MASH with scarred liver tissue

    💵 May compensate

    📍 GSK Investigational Site · Arcadia, CA · +39 more US sites · Get directions →

    The purpose of this study is to assess the safety and efficacy of efimosfermin alfa in the resolution of steatohepatitis and improvement of liver-related clinical outcome compared to placebo in individuals with MASH and biopsy-confirmed F2- or F3-stage fibrosis.

    ✓ Study care freePhase 3Ages 18–75Learn more →
  • Dementia / Alzheimer's

    Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease

    Testing a brain stimulation approach to study memory and thinking in people with early

    💵 May compensate

    📍 Massachusetts General Hospital · Charlestown, MA · Get directions →

    The project is a placebo-controlled study that aims to use closed-loop transcranial alternating current stimulation (tACS) to study patients with symptoms of mild cognitive impairment which is likely due to Alzheimer's disease or another form of dementia (AD-MCI). Patients will undergo an EEG and complete some questionnaires and computer tasks during each study visit.

    ✓ Study care freeAges 50–80Learn more →
  • Dementia / Alzheimer's

    Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

    Testing an Alzheimer’s treatment in people with dementia and gum infection

    💵 May compensate

    📍 Banner Alzheimer's Institute · Phoenix, AZ · +38 more US sites · Get directions →

    This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental decline in the last year and who have P. gingivalis (Pg) infection.

    ✓ Study care freePhase 2Ages 55–80Learn more →
  • Sickle cell disease

    Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

    Testing higher doses of VAS-101 in people with stable sickle cell disease

    💵 May compensate

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: Sickle cell disease (SCD) is an inherited blood disorder. The disease affects the ability of red blood cells to carry oxygen.

    ✓ Study care freePhase 1Ages 18–90Learn more →
  • Kidney disease

    Kidney Health: Eat Well, Live Well

    Testing a 6-month community program about diet for early kidney disease

    💵 May compensate

    📍 Harris Health System's Outpatient Center · Houston, TX · +2 more US sites · Get directions →

    This two-arm, parallel randomized trial study will assess the efficacy of a 6-month (26 weeks) community-based program in reducing kidney injury (as Urine Albumin to Creatinine ratio, uACR), cardiovascular risk (as Hemoglobin A1C and blood pressure), mental health (as PHQ-8) and diet quality (as fruits and vegetables intake and Healthy Eating Index) in community-dwelling, low-income adults diagnosed with early chronic kidney disease (stages 2 or 3 and not on kidney replacement therapies) compared to educational materials and usual care alone.

    ✓ Study care freeAges 18+Learn more →
  • Anxiety

    Transcranial Alternating Current Stimulation (tACS) for the Treatment of Anxiety in Veterans: An Open-Label Pilot Study

    Testing a wearable brain stimulation device to treat anxiety in veterans

    💵 May compensate

    📍 Birmingham VA · Birmingham, AL · Get directions →

    Transcranial alternating current stimulation (tACS) in a wearable brain stimulation device that delivers a low intensity, pulsed, alternating current via scalp electrodes. Prior sham-controlled clinical trials have shown the therapeutic effects and safety of tACS for the treatment of anxiety and depression.

    ✓ Study care freeAges 19–70Learn more →
  • High blood pressure

    Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

    Testing a device used through a blood-vessel procedure for type 2 diabetes and high blood pressure

    💵 May compensate

    📍 Hospital Paitilla Clinicas y Hospitales · Panama City, · Get directions →

    This study is assess the safety and performance of the Neurotronic Infusion catheter for treatment of patients with Type 2 Diabetes (T2DM) and hypertension.

    ✓ Study care freePhase 1Ages 21–65Learn more →
  • Sickle cell disease

    Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0

    Testing whether acupuncture can reduce pain in people with sickle cell disease

    💵 May compensate

    📍 Indiana University School of Medicine · Indianapolis, IN · Get directions →

    The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupuncture analgesia in patients with sickle cell disease.

    ✓ Study care freeAges 14–80Learn more →
  • Anxiety

    Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings

    Testing different ways to deliver talk therapy skills for kids with anxiety

    💵 May compensate

    📍 Bradley Hospital · East Providence, RI · Get directions →

    The purpose of this study is to test how the delivery of Cognitive Behavioral Therapy (CBT) for pediatric anxiety and OCD via different methods might increase its availability and effectiveness. CBT involves teaching the patient skills to enable them to gradually come into contact with feared situations.

    ✓ Study care freeAges 5–18Learn more →
  • Obesity / overweight

    Metabolic Health, Bones and Nuts During Weight Loss in Adults

    Testing how diet changes with weight loss affect metabolic health and bones, including nuts

    💵 May compensate

    📍 Rutgers University - NJ Inst Food Nutrition & Health · New Brunswick, NJ · Get directions →

    The aging population is rapidly increasing, and it is important to identify dietary factors that can prevent disease and promote health in this group. Legumes, such as peanuts, are a plant-based food high in protein and unsaturated fat making this a healthy choice but are not consumed frequently enough in older adults.

    ✓ Study care freeAges 50–75Learn more →
  • Lupus (SLE)

    INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use

    Studying how adding anifrolumab to usual care affects lupus in real life

    💵 May compensate

    📍 Research Site · Buenos Aires, · Get directions →

    INTERSTELLAR study will generate critical prospective real-world evidence on the benefits of adding Anifrolumab to standard of care treatment for SLE in routine clinical practice, to inform physicians, payers and patients. The study will use clinical assessments that are relevant for SLE-treating physicians in routine clinical practice, as well as introduce a specific measure for skin manifestations to affirm the potency of anifrolumab in treating SLE-related skin manifestations.

    ✓ Study care freeAges 18+Learn more →
  • Kidney disease

    Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease

    Testing kidney disease drug effects and safety in teens with early CKD

    💵 May compensate

    📍 Instituto de atención Integral de Enfermedades Renales del Estado de Aguascalientes · Aguascalientes, Aguascalientes · Get directions →

    Chronic kidney disease (CKD) is highly prevalent in the state of Aguascalientes, Mexico, particularly among adolescents and young adults. Epidemiologic and histologic studies suggest that this burden is largely driven by reduced nephron endowment of prenatal origin, leading to compensatory glomerular hyperfiltration, adaptive podocytopathy, and persistent albuminuria at early stages of disease.

    ✓ Study care freePhase 4Ages 14–18Learn more →
  • Dementia / Alzheimer's

    Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1

    Testing a brain scan tracer to measure inflammation in dementia

    💵 May compensate

    📍 Washington University School of Medicine · St Louis, MO · Get directions →

    This study involves a brain positron emission tomography (PET) scan with a new, investigational radioactive tracer called \[11C\]-CS1P1 to identify inflammation in the brain by testing with healthy older adults and with cognitively impaired older adults.

    ✓ Study care freeAges 50+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    New Heart Imaging Techniques to Evaluate Possible Heart Disease

    Testing new heart imaging to check for possible heart disease

    💵 May compensate

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: \- Imaging tests, such as magnetic resonance imaging (MRI), can provide information about heart and blood vessels. The tests let doctors can see the amount of blood vessel narrowing and vessel wall thickness.

    ✓ Study care freeAges 18–100Learn more →
  • Anxiety

    Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating Disorders

    Testing a non-invasive brain stimulation device to help treat mealtime anxiety in adults with eating

    💵 May compensate

    📍 Rogers Behavioral Health · Oconomowoc, WI · Get directions →

    The study is to evaluate the feasibility of using a non-invasive brain stimulation device in a sample of inpatients with eating disorders (ED). The study will help researchers evaluate whether their device protocol is practical for eating disorder inpatients as a way to manage eating disorder and anxiety symptoms.

    ✓ Study care freeAges 18–30Learn more →
  • Dementia / Alzheimer's

    Intervention for Communication Quality of Life in Primary Progressive Aphasia

    Testing an online speech and language program to improve communication and quality of life for

    💵 May compensate

    📍 University of Texas · Austin, TX · Get directions →

    The goal of this clinical trial is to learn whether a personalized, multi-component, virtual speech language treatment program can improve communication and quality of life for adults with primary progressive aphasia (PPA) and their primary communication partners. The study will enroll participants who speak English and/or Spanish.

    ✓ Study care freeAges 40+Learn more →
  • Crohn's / ulcerative colitis (IBD)

    The Influence of a Fasting Mimicking Diet on Ulcerative Colitis

    Testing how a fasting-like diet affects inflammation in ulcerative colitis

    💵 May compensate

    📍 Stanford University · Palo Alto, CA · Get directions →

    The purpose of this study is to see how a diet that mimics fasting effects inflammation in patients with mild to moderate Ulcerative Colitis (UC). The diet may allow users to receive the benefits of fasting while also being able to enjoy food (the ingredients of which are GRAS (generally recognized as safe) by the Food and Drug Administration (FDA).

    ✓ Study care freeAges 18–70Learn more →
  • Type 2 diabetes

    A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

    Testing whether CX11 tablets are safe and work in people with type 2 diabetes not well controlled on

    💵 May compensate

    📍 Central Research Associates - Flourish - PPDS · Birmingham, AL · +30 more US sites · Get directions →

    This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good blood sugar control while taking a steady dose of metformin, with or without a steady dose of an SGLT2 inhibitor, for at least 90 days. The study is being done at multiple medical centers.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Type 2 diabetesKidney disease

    Mechanism of SGLT2 Inhibition in the Kidney

    Testing how SGLT2 medicines affect kidney function in type 2 diabetes

    💵 May compensate

    📍 University of Michigan · Ann Arbor, MI · Get directions →

    The goal of this open-label, non-randomized clinical trial is to determine what effects, if any, an FDA-approved drug class known as SGLT2 inhibitors (Canagliflozin or INVOKANA) has any protective effects on kidney function in Type 2 diabetes. We are looking for participants 18-80 years of age, who have had a clinical diagnosis of Type 2 diabetes for ≥ 3 years.

    ✓ Study care freePhase 4Ages 18–80Learn more →
  • Fatty liver disease (NASH/MASH)

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

    Testing how the liver responds to glucose in fatty liver disease, and semaglutide’s effect

    💵 May compensate

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: In non-alcoholic fatty liver disease (NAFLD), fat accumulates in the liver and can cause damage. Researchers want to learn what causes the damage NAFLD, and to see if a medication can help.

    ✓ Study care freePhase 2Ages 18–100Learn more →
  • Obesity / overweight

    Experimental Approach to Test Predictions of Body Weight Regulation Models

    Testing how body weight regulation models explain obesity

    💵 May compensate

    📍 Pennington Biomedical Research Center · Baton Rouge, LA · Get directions →

    The regulation of human body weight and fatness is not fully understood. Although some models of regulation have been proposed (set point, dual-intervention point, others), no studies have been designed to test their predictions.

    ✓ Study care freeAges 18–40Learn more →
  • Type 2 diabetes

    HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

    Testing different doses of a treatment to see safety and effects on blood sugar in people with type

    💵 May compensate

    📍 Alliance Clinical Canoga Park (Hope Clinical Research) · Canoga Park, CA · +24 more US sites · Get directions →

    Blood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Obesity / overweightFatty liver disease (NASH/MASH)

    Human Models of Selective Insulin Resistance: Alpelisib, Part I

    Testing how insulin works in healthy people versus people at risk for type 2 diabetes

    💵 May compensate

    📍 Columbia University Irving Medical Center · New York, NY · Get directions →

    The goal of this clinical trial is to understand how the blood sugar-lowering hormone insulin works in healthy adults versus those who are at risk for type 2 diabetes. The study will use a drug called alpelisib, which interferes with insulin's actions in the body, to answer the study's main question: does the liver continue to respond to insulin's stimulation of fat production even when it loses the ability to stop making glucose (sugar) in response to insulin.

    ✓ Study care freePhase 1Ages 18–70Learn more →
  • Obesity / overweight

    A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

    Testing a diabetes drug in people with fatty liver and excess weight

    💵 May compensate

    📍 Arizona Clinical Trials · Chandler, AZ · +22 more US sites · Get directions →

    The main objective of this trial will be to determine whether maridebart cafraglutide is superior to placebo on reduction in liver fat content and body weight in participants living with obesity or overweight and elevated liver fat content, when administered in conjunction with reduced-calorie diet and increased physical activity.

    ✓ Study care freePhase 2Ages 18–99Learn more →
  • Fatty liver disease (NASH/MASH)

    Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

    Testing how SGLT2 inhibitors work for fatty liver disease in obese teens

    💵 May compensate

    📍 Ann & Robert H Lurie Children's Hospital of Chicago · Chicago, IL · Get directions →

    This study is a randomized, double-blind, placebo-controlled trial specifically designed to evaluate the preliminary feasibility, initial efficacy and safety of SGLT2 inhibitors for treating NAFLD in adolescents with obesity.

    ✓ Study care freePhase 2Ages 16–20Learn more →
  • Crohn's / ulcerative colitis (IBD)

    Fermented Food-Supplemented Diet in Ulcerative Colitis

    Testing whether a diet with fermented food supplements affects inflammation and quality of life in

    💵 May compensate

    📍 Stanford University · Palo Alto, CA · Get directions →

    The purpose of this study is to see how a diet that supplements fermented foods effects inflammation and quality of life in patients with mild to moderate Ulcerative Colitis (UC). There is a paucity of research and an enormous need for better understanding of diet and intestinal inflammation.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightFatty liver disease (NASH/MASH)

    Fibrosis Lessens After Metabolic Surgery

    Testing whether metabolic surgery can reduce liver scarring in obesity

    💵 May compensate

    📍 Banner Health Center · Phoenix, AZ · +3 more US sites · Get directions →

    Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), a major global public health concern, is commonly associated with obesity, diabetes, and dyslipidemia. MASLD is currently the most common cause of chronic liver disease affecting about 80% of people with obesity, ranging from simple fat deposits in the liver to Metabolic Dysfunction-Associated Steatohepatitis (MASH), cellular injury, advanced fibrosis, cirrhosis, or hepatocellular carcinoma.

    ✓ Study care freePhase 4Ages 18–75Learn more →
  • DepressionAnxiety

    Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

    Testing psilocybin-assisted therapy for depression and anxiety in people with advanced cancer

    💵 May compensate

    📍 MD Anderson Cancer Center · Houston, TX · Get directions →

    To learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy on depression and/or anxiety in participants who are being treated for advanced cancer.

    ✓ Study care freePhase 2Ages 25+Learn more →
  • Fatty liver disease (NASH/MASH)

    A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

    Testing whether pegozafermin is safe and works for MASH-related liver cirrhosis

    💵 May compensate

    📍 89bio Clinical Study Site · Birmingham, AL · +39 more US sites · Get directions →

    The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis stage F4 MASH \[previously known as nonalcoholic steatohepatitis, NASH\]).

    ✓ Study care freePhase 3Ages 18–75Learn more →
  • Depression

    Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression

    Testing ketamine infusions plus brief counseling for veterans with low back pain and depression

    💵 May compensate

    📍 VA Ann Arbor Healthcare System, Ann Arbor, MI · Ann Arbor, MI · Get directions →

    This is a pilot study to evaluate the feasibility, acceptability, and safety of ketamine infusions followed by a brief behavioral intervention in Veterans with chronic low back pain and depression.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Parkinson's disease

    SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

    Testing a single dose of SER-252 in people with Parkinson’s disease

    💵 May compensate

    📍 Rocky Mountain Clinical Research · Englewood, CO · +3 more US sites · Get directions →

    This is a randomized, placebo-controlled, single ascending dose (SAD) study of SER-252 in participants with Parkinson's Disease (PD) and motor fluctuations.

    ✓ Study care freePhase 1Ages 40–80Learn more →
  • DepressionAnxiety

    TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

    Testing psilocybin-assisted therapy for depression and anxiety in cancer survivors

    💵 May compensate

    📍 The University of Texas M. D. Anderson Cancer Center · Houston, TX · Get directions →

    This clinical research study is to learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy for cancer survivors with depression and/or anxiety.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Obesity / overweight

    TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation

    Testing tirzepatide to treat obesity in people with atrial fibrillation

    💵 May compensate

    📍 Cleveland Clinic · Cleveland, OH · Get directions →

    This is a single center randomized double blind controlled study of patients (BMI ≥ 27 kg/m2) with obesity and Atrial Fibrillation (AFIB) randomized to Tirzepatide vs. placebo.

    ✓ Study care freePhase 2Ages 18–80Learn more →
  • Crohn's / ulcerative colitis (IBD)

    Treatment of UC With Novel Therapeutics

    Testing an oral medicine to treat mild ulcerative colitis over 12 weeks

    💵 May compensate

    📍 Brigham and Women's Hospital · Chestnut Hill, MA · Get directions →

    This study is a clinical trial being done to investigate the efficacy of drug BRS201 as a treatment in patients with active mild ulcerative colitis. Participation in this study will take 12 weeks long and the study is structured as a crossover study in which participants will take the study drug for 4 weeks and a placebo drug for 4 weeks in a randomized order in the form of an oral medication.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Crohn's / ulcerative colitis (IBD)

    Study of Novel Therapeutics for Acute Remedy of Colitis

    Testing a new treatment in adults with acute ulcerative colitis

    💵 May compensate

    📍 Brigham and Women's Hospital · Chestnut Hill, MA · +1 more US site · Get directions →

    This study is a clinical trial being done to investigate the efficacy of drug BRS201 as a treatment in patients with acute ulcerative colitis. Patients who qualify are adults who have not responded to treatments for their severe ulcerative colitis.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Depression

    Positive Processes and Transition to Health - Single-Session (PATH-SS)

    Testing a brief talk therapy to reduce depression and trauma distress after sexual assault

    💵 $20

    📍 Case Western Reserve University · Cleveland, OH · Get directions →

    The goal of this clinical trial is to test a brief, new psychotherapy (called Positive Processes and Transition to Health - Single Session, or PATH-SS) that aims to provide relief for people who are suffering after experiencing a sexual assault. This research will explore whether this new psychotherapy reduces sexual assault related distress, including posttraumatic stress and depression symptoms.

    ✓ Study care freeAges 18–65Learn more →
  • Lupus (SLE)

    A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

    Testing whether cenerimod added to usual treatment helps adults with active lupus nephritis

    💵 May compensate

    📍 Alloy Clinical Research LLC · Kissimmee, FL · +10 more US sites · Get directions →

    The goal of this clinical trial is to learn if cenerimod, on top of regular treatment, works to treat active lupus nephritis in adults with systemic lupus erythematosus and active lupus nephritis. It will also learn about the safety of cenerimod.

    ✓ Study care freePhase 3Ages 18–75Learn more →
  • Heart / cardiovascular diseaseKidney disease

    Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

    Testing whether sotagliflozin can slow kidney damage in type 1 diabetes

    💵 May compensate

    📍 Stanford University Medical Center · Stanford, CA · +12 more US sites · Get directions →

    Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 diabetes (T1D) remains unknown because of the few studies in this population, due to concerns about the increase in risk of diabetic ketoacidosis (DKA, a serious, potentially fatal acute complication of diabetes due to the accumulation of substances called ketone bodies) observed with SGLT2i therapy in T1D.

    ✓ Study care freePhase 3Ages 18–75Learn more →
  • Depression

    BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

    Testing a combination device treatment for depression and sexual function in women

    💵 May compensate

    📍 Luxury Psychiatry Clinic · Winter Garden, FL · +1 more US site · Get directions →

    The goal of this clinical trial is to evaluate if the combined treatment with EXOMIND (BTL-699-2) and EMSELLA (HPM-6000UF) devices is able to improve depressive symptoms and sexual function in women who are perimenopausal or postmenopausal without an alternative medical cause before enrollment in the study and are aged 40 years and older. The main question it aims to answer is: Does the combined treatment with EXOMIND (BTL-699-2) and EMSELLA (HPM-6000UF) devices improve depressive symptoms and urinary incontinence?

    ✓ Study care freeAges 40+WomenLearn more →
  • Fatty liver disease (NASH/MASH)

    A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

    Testing efimosfermin in people with MASH-related compensated cirrhosis

    💵 May compensate

    📍 GSK Investigational Site · Chandler, AZ · +29 more US sites · Get directions →

    The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants with metabolic dysfunction associated steatohepatitis (MASH) and compensated cirrhosis consistent with stage F4 fibrosis.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • Type 2 diabetes

    Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

    Testing how semaglutide affects blood sugar and weight in people with spinal cord injury and type 2

    💵 May compensate

    📍 University Health - Texas Diabetic Institute · San Antonio, TX · +1 more US site · Get directions →

    It is not known whether a new diabetes drug, semaglutide, is an effective treatment for type 2 diabetes for persons with spinal cord injury (SCI), a population at higher risk for this condition. Therefore, this study looks at the effect of semaglutide on glucose levels in the body and other information about type 2 diabetes and obesity.

    ✓ Study care freePhase 4Ages 18–70Learn more →
  • COPD (chronic lung disease)

    PiMZ Longitudinal Cohort (PiMZ Logic)

    Tracking how COPD affects people with the PiMZ form of alpha-1 anti-trypsin deficiency

    💵 May compensate

    📍 University of Alabama at Birmingham · Birmingham, AL · +4 more US sites · Get directions →

    Alpha-1 Anti-trypsin Deficiency (AATD) is a genetic disease with lung and liver disease presentations. Presentations are variable in the heterozygous population, the most predominant genotype being PiMZ.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweight

    Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes

    Testing a program to help Latinas manage eating cues to prevent type 2 diabetes and reduce weight

    💵 May compensate

    📍 UCSD Center for Healthy Eating and Activity Research (CHEAR · La Jolla, CA · Get directions →

    Adapt the Regulation of Cues (ROC) treatment program for Latinas to see if it can treat prediabetes and prevent developing of Type 2 Diabetes and reduce weight.

    ✓ Study care freeAges 18–55WomenLearn more →
  • Multiple sclerosis (MS)

    Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod

    Testing whether ozanimod is safe and works as a step-down treatment for stable multiple sclerosis

    💵 May compensate

    📍 University of Colorado Anschutz Medical Campus · Aurora, CO · +2 more US sites · Get directions →

    A multi-center pilot study to evaluate safety and efficacy of ozanimod as de-escalation therapy in clinically stable MS patients previously treated with anti-CD20 therapy.

    ✓ Study care freePhase 4Ages 18+Learn more →
  • Obesity / overweight

    Redefining BMI: The Body, Mind, and Inflammation Trial

    Testing an intensive lifestyle program to improve weight and inflammation in young adults with

    💵 May compensate

    📍 Virginia Commonwealth Universtity · Richmond, VA · Get directions →

    Emerging adulthood (18-25 years of age) is a critical developmental window to promote weight management and cardiometabolic health, particularly for emerging adult women. The primary purpose of this study is to test the preliminary efficacy of the intensive lifestyle intervention for EA women in reducing adiposity, as well as improving biomarkers of inflammation and metabolic risk over 12 months compared with a traditional behavioral weight loss intervention.

    ✓ Study care freeAges 18–25WomenLearn more →
  • Crohn's / ulcerative colitis (IBD)

    Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

    Testing whether mirikizumab is safe and works for people with Crohn’s strictures

    💵 May compensate

    📍 Digestive & Liver Center of Florida · Orlando, FL · +1 more US site · Get directions →

    This is an open-label, single-arm, phase 4 study to assess the safety and efficacy of mirikizumab in approximately 60 participants with stricturing CD.

    ✓ Study care freePhase 4Ages 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Prevention of Progression of Prediabetes, Obesity and CV Risk

    Testing ways to stop prediabetes and obesity from getting worse

    💵 May compensate

    📍 University of Texas Health Science Center at San Antonio · San Antonio, TX · Get directions →

    The investigators are studying how to help people with prediabetes (Pre-DM) and obesity. The goal is to use new and affordable treatments to bring blood sugar levels back to normal and help participants to lose weight.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Fatty liver disease (NASH/MASH)

    Evaluating the Pharmacokinetics and Safety of Miricorilant

    Testing how a drug works in the body and its safety in adults with MASH

    💵 May compensate

    📍 Site# 433 · San Antonio, TX · Get directions →

    A Phase 1b, Open-Label Study Evaluating the Pharmacokinetics and Safety of Miricorilant in Adult Patients With Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • Fatty liver disease (NASH/MASH)

    Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD

    Testing a medicine at two doses for safety and effects on fats in people with high triglycerides and

    💵 May compensate

    📍 OrsoBio Research Site · Guadalajara, Jalisco · Get directions →

    This is a Phase 2a, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability, and efficacy of 2 dose levels of TLC-2716 in subjects with hypertriglyceridemia and nonalcoholic fatty liver disease as assessed by changes in fasting triglycerides, liver steatosis by MRI, and other biomarkers.

    ✓ Study care freePhase 2Ages 18–70Learn more →
  • COPD (chronic lung disease)

    Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure

    Comparing inhaled triple versus double medicines for COPD lung airways after wood smoke exposure

    💵 May compensate

    📍 Insituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas" · Mexico City, Tlalpan · Get directions →

    This phase IV randomized controlled clinical trial intend to compare the effect of three close standard inhaled triple therapies and one close standard inhaled double therapy on the small airway in patients with Chronic Obstructive Pulmonary Disease (COPD-B) and chronic bronchitis without obstruction (BCNO) exposed to wood smoke. The treatment phase duration is of 3 months.

    ✓ Study care freePhase 4Ages 35–85WomenLearn more →
  • DepressionAnxiety

    Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

    Testing whether pregnenolone pills affect brain function and depression in people with HIV

    💵 May compensate

    📍 Massachusetts General Hospital · Boston, MA · Get directions →

    This study will determine the effects of pregnenolone on brain function, inflammation and depressive symptoms in people with HIV who have depression. Participants in this study will receive a pill of either pregnenolone or placebo, and can stay on their current antidepression medications.

    ✓ Study care freePhase 2Ages 18–85Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

    Testing maridebart cafraglutide with standard care to reduce heart failure events in obese people

    💵 May compensate

    📍 University of Alabama Saint Vincent's Birmingham · Birmingham, AL · +39 more US sites · Get directions →

    This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection fraction (HFpEF) and HF with mildly reduced ejection fraction (HFmrEF) who are obese. This is a phase 3, global, multicenter, 2-part trial with a double-blind period and an open-label extension (OLE).

    ✓ Study care freePhase 3Ages 18–99Learn more →
  • Fatty liver disease (NASH/MASH)

    Endoscopic Ultrasound Shear Wave Elastography Study

    Testing an ultrasound imaging method during endoscopy to measure liver scarring

    💵 May compensate

    📍 Brigham and Women's Hospital · Boston, MA · +1 more US site · Get directions →

    This study shall be a prospective, multicenter, single arm, consecutive, interventional study conducted in a post-market setting using commercially available devices. Consecutive, eligible patients with clinical suspicion of MASLD or MASH reporting for an endoscopic ultrasound and liver biopsy for evaluation of fibrosis will be enrolled.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweight

    Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors

    Testing a phone-based weight management program for young cancer survivors with obesity

    💵 May compensate

    📍 University of North Carolina at Chapel Hill · Chapel Hill, NC · Get directions →

    The AYA WELL study is a 2-arm randomized clinical trial to test the efficacy of a theory-based, mHealth weight management intervention adapted specifically for adolescent and young adult cancer survivors compared to a self-guided arm. Participants, diagnosed with cancer between ages 15-39, currently age 18-39, post-treatment at least 6 months, and who have overweight or obesity will be randomized to receive either: 1) a comprehensive mHealth weight management program (intervention) or 2) digital tools + health education + peer support (self-guided) over 12 months.

    ✓ Study care freeAges 18–39Learn more →
  • Obesity / overweightHigh blood pressure

    Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

    Testing treatments to lower high pressure in liver veins in people with advanced liver disease and

    💵 May compensate

    📍 Cleveland Clinic Main Campus · Cleveland, OH · Get directions →

    Cirrhosis is a form of advanced liver disease that can lead to serious complications, especially when combined with severe obesity. Many patients with cirrhosis also develop a condition called clinically significant portal hypertension (CSPH), which is increased pressure in the veins of the liver.

    ✓ Study care freePhase 4Ages 18–70Learn more →
  • Type 2 diabetes

    Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers

    Testing software that helps healthcare providers choose diabetes medicines for type 2 diabetes

    💵 May compensate

    📍 University of Virginia Center for Diabetes Technology · Charlottesville, VA · Get directions →

    Decision Support System (Software) for multi antidiabetic drug therapy use in type 2 diabetes (T2D).

    ✓ Study care freeAges 18+Learn more →
  • Fatty liver disease (NASH/MASH)

    Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

    Testing how to predict liver outcomes in people with NASH and advanced scarring

    💵 May compensate

    📍 Mayo Clinic in Rochester · Rochester, MN · +1 more US site · Get directions →

    Nonalcoholic Steatohepatitis (NASH) is a condition with increased amount of fat, inflammation and scarring in the liver. In compensated cirrhosis, the liver is coping with this damage and maintaining its important functions.

    ✓ Study care freeAges 18+Learn more →
  • Showing the first 60 of 105. Add filters or a location to narrow down.